321 related articles for article (PubMed ID: 32562128)
1. Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma.
Bueno M; Papazoglou A; Valenzi E; Rojas M; Lafyatis R; Mora AL
Curr Rheumatol Rep; 2020 Jun; 22(8):37. PubMed ID: 32562128
[TBL] [Abstract][Full Text] [Related]
2. Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease.
Yang MM; Lee S; Neely J; Hinchcliff M; Wolters PJ; Sirota M
Front Immunol; 2024; 15():1326922. PubMed ID: 38348044
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?
Luckhardt TR; Thannickal VJ
Curr Opin Rheumatol; 2015 Nov; 27(6):571-6. PubMed ID: 26398012
[TBL] [Abstract][Full Text] [Related]
4. Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population.
DePianto DJ; Heiden JAV; Morshead KB; Sun KH; Modrusan Z; Teng G; Wolters PJ; Arron JR
JCI Insight; 2021 Apr; 6(8):. PubMed ID: 33705361
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease.
Yang MM; Lee S; Neely J; Hinchcliff M; Wolters PJ; Sirota M
bioRxiv; 2023 Nov; ():. PubMed ID: 37986995
[TBL] [Abstract][Full Text] [Related]
6. Role of cellular senescence in the pathogenesis of systemic sclerosis.
Tsou PS; Shi B; Varga J
Curr Opin Rheumatol; 2022 Nov; 34(6):343-350. PubMed ID: 35979691
[TBL] [Abstract][Full Text] [Related]
7. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
[TBL] [Abstract][Full Text] [Related]
8. Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis.
Piera-Velazquez S; Jimenez SA
Curr Rheumatol Rep; 2015 Jan; 17(1):473. PubMed ID: 25475596
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast Senescence in Idiopathic Pulmonary Fibrosis.
Lin Y; Xu Z
Front Cell Dev Biol; 2020; 8():593283. PubMed ID: 33324646
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts.
Schuliga M; Pechkovsky DV; Read J; Waters DW; Blokland KEC; Reid AT; Hogaboam CM; Khalil N; Burgess JK; Prêle CM; Mutsaers SE; Jaffar J; Westall G; Grainge C; Knight DA
J Cell Mol Med; 2018 Dec; 22(12):5847-5861. PubMed ID: 30255990
[TBL] [Abstract][Full Text] [Related]
11. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
Front Immunol; 2020; 11():1990. PubMed ID: 33013852
[TBL] [Abstract][Full Text] [Related]
12. Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosis.
Merkt W; Bueno M; Mora AL; Lagares D
Semin Cell Dev Biol; 2020 May; 101():104-110. PubMed ID: 31879264
[TBL] [Abstract][Full Text] [Related]
13. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
[TBL] [Abstract][Full Text] [Related]
14. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria, telomeres and cell senescence: Implications for lung ageing and disease.
Birch J; Barnes PJ; Passos JF
Pharmacol Ther; 2018 Mar; 183():34-49. PubMed ID: 28987319
[TBL] [Abstract][Full Text] [Related]
16. Cellular senescence in aging: Molecular basis, implications and therapeutic interventions.
Princilly J; Veerabhadrappa B; Rao NN; Dyavaiah M
Adv Protein Chem Struct Biol; 2023; 136():1-33. PubMed ID: 37437975
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.
Gleason JB; Patel KB; Hernandez F; Hadeh A; Highland KB; Rahaghi F; Mehta JP
Lung; 2017 Aug; 195(4):403-409. PubMed ID: 28456874
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.
Mora AL; Bueno M; Rojas M
J Clin Invest; 2017 Feb; 127(2):405-414. PubMed ID: 28145905
[TBL] [Abstract][Full Text] [Related]
20. Targeting Mitochondrial Metabolism as a Strategy to Treat Senescence.
Lee YH; Park JY; Lee H; Song ES; Kuk MU; Joo J; Oh S; Kwon HW; Park JT; Park SC
Cells; 2021 Nov; 10(11):. PubMed ID: 34831224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
